Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Multi-Marker Screening and Randomised Patient Treatment with Aspirin for Evidence-based Pre-eclampsia Prevention
2013-003778-29Phase 3Completed
- Sponsor
- University College London
- Start
- Dec 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in preeclampsia, maternal hypertension (HDP), intrauterine growth restriction (IUGR) and 2 more comparing Low-dose aspirin with Placebo (2 arms). Primary endpoint: Incidence of preterm pre-eclampsia. Started Dec 2013; status: completed.
02
Drugs
aspirin
03
Conditions
preeclampsiamaternal hypertension (HDP)intrauterine growth restriction (IUGR)abruptio placentaepreterm birth
Beyond the preview
Go deeper on 2013-003778-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003778-29.